Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

bioAffinity Technologies (BIAF) Tax Provisions (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Tax Provisions for 4 consecutive years, with $3182.0 as the latest value for Q3 2025.

  • On a quarterly basis, Tax Provisions rose 24.35% to $3182.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $40861.0, a 193.06% increase, with the full-year FY2024 number at $11650.0, down 44.51% from a year prior.
  • Tax Provisions was $3182.0 for Q3 2025 at bioAffinity Technologies, down from $28984.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $28984.0 in Q2 2025 to a low of $300.0 in Q3 2022.
  • A 4-year average of $6330.2 and a median of $3427.0 in 2024 define the central range for Tax Provisions.
  • Peak YoY movement for Tax Provisions: soared 664.67% in 2023, then plummeted 68.93% in 2024.
  • bioAffinity Technologies' Tax Provisions stood at $300.0 in 2022, then surged by 664.33% to $2293.0 in 2023, then grew by 11.6% to $2559.0 in 2024, then grew by 24.35% to $3182.0 in 2025.
  • Per Business Quant, the three most recent readings for BIAF's Tax Provisions are $3182.0 (Q3 2025), $28984.0 (Q2 2025), and $8695.0 (Q1 2025).